GHB and Meth: Unpacking the Dangers with Dr. Shalini Arunogiri
The implications of this are clearly that if the person is using both of the substances together, we need to start understanding what the implications this has for harm reduction.
What happens when a medical drug becomes a recreational hazard? Dr. Rob Calder sits down with Dr. Shalini Arunogiri to tackle this question head-on in an eye-opening episode of Addiction Audio. GHB, or gamma-hydroxybutyrate, is known both for its legitimate medical uses and its darker side as a party drug. Dr. Arunogiri dives into her research on the alarming rise in GHB-related harms, particularly when mixed with methamphetamine.
From 2012 to 2018, ambulance attendances in Victoria, Australia saw a worrying trend: more people were being treated for issues related to GHB and its combination with methamphetamine. This episode doesn't just throw statistics at you; it brings the data to life, showing the real-world implications of these findings. Imagine the strain on emergency services and the ripple effect on public health. But it's not all doom and gloom. Dr.
Arunogiri also discusses the urgent need for tailored treatment approaches for those caught in the web of GHB and methamphetamine dependence. She emphasizes the importance of understanding core use patterns and primary drug dependencies to craft more effective harm reduction strategies. This episode is a must-listen for anyone interested in the nuances of addiction, whether you're a researcher, clinician, or someone with lived experience.
It’s a deep dive into a complex issue, offering both sobering facts and a glimmer of hope through better treatment methods.